This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Cochlear (OtherCHEOF), CervoMed (CRVO) and Community Health (CYH)

Tipranks - Tipranks - Sat Apr 25, 4:10AM CDT

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Cochlear (CHEOF), CervoMed (CRVO) and Community Health (CYH).

Claim 30% Off TipRanks

Cochlear (CHEOF)

Morgan Stanley analyst David Bailey upgraded Cochlear to Hold yesterday and set a price target of A$119.00. The company’s shares closed last Thursday at $67.83.

According to TipRanks.com, Bailey is a 4-star analyst with an average return of 9.9% and a 43.3% success rate. Bailey covers the Healthcare sector, focusing on stocks such as Fisher & Paykel Healthcare Corporation Limited, Telix Pharmaceuticals, and Ramsay Health Care. ;'>

Currently, the analyst consensus on Cochlear is a Moderate Buy with an average price target of $122.88, representing a 74.0% upside. In a report released yesterday, Morgans also maintained a Hold rating on the stock with a A$107.17 price target.

See today’s best-performing stocks on TipRanks >>

CervoMed (CRVO)

In a report released yesterday, Sumant Kulkarni from Canaccord Genuity reiterated a Buy rating on CervoMed, with a price target of $27.00. The company’s shares closed last Thursday at $3.85, close to its 52-week low of $1.80.

According to TipRanks.com, Kulkarni is a 4-star analyst with an average return of 7.1% and a 44.6% success rate. Kulkarni covers the Healthcare sector, focusing on stocks such as MapLight Therapeutics, Inc., ACADIA Pharmaceuticals, and Definium Therapeutics. ;'>

Currently, the analyst consensus on CervoMed is a Strong Buy with an average price target of $20.80, representing a 425.3% upside. In a report released yesterday, Roth MKM also maintained a Buy rating on the stock with a $11.00 price target.

Community Health (CYH)

Oppenheimer analyst Michael Wiederhorn maintained a Buy rating on Community Health yesterday and set a price target of $4.00. The company’s shares closed last Thursday at $2.49.

According to TipRanks.com, Wiederhorn is a 5-star analyst with an average return of 9.1% and a 57.1% success rate. Wiederhorn covers the Healthcare sector, focusing on stocks such as Guardian Pharmacy Services, Inc. Class A, The Ensign Group, and HCA Healthcare. ;'>

The word on The Street in general, suggests a Hold analyst consensus rating for Community Health with a $3.54 average price target.

Read More on CHEOF:

Disclaimer & DisclosureReport an Issue

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2026.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).